Enhancing Health Outcomes with Geriatric-Specific Cancer Rehabilitation

By Melike Belenli Gümüş

September 19, 2024

Introduction

With the ageing population, the incidence of cancer among older adults is set to surge significantly. By 2040, it is projected that more than 70% of all cancer cases will be diagnosed in individuals aged 65 and above. Older cancer patients often face intricate health challenges due to various factors such as comorbid chronic conditions, functional limitations, malnutrition, cognitive decline, and geriatric syndromes. These complexities can impede their ability to withstand and recover from cancer treatments. Compared to younger patients, older individuals undergoing cancer treatment often experience high level of toxicity, prolonged hospital stays, treatment delays, incomplete therapy, and diminished quality of life (QoL). Studies show that up to half of older cancer survivors report enduring physical disabilities and reduced health status even a decade post-diagnosis. Therefore, tailored geriatric-specific cancer rehabilitation programmes are necessary to enhance the QoL for older adults undergoing cancer treatment.

Evaluating Geriatric-Specific Cancer Rehabilitation Programs

A recent study conducted in Al-Ahsa, Saudi Arabia, examined the efficacy of a tailored geriatric cancer rehabilitation programme on the QoL of 130 cancer patients aged 65 to over 80, with a slight concentration in the 70-74 age group. The most common cancer types among participants were breast, prostate, lung, and colorectal cancers.

The research revealed that participants in the rehabilitation group exhibited significantly higher QoL scores across physical, social, and functional domains compared to those receiving standard oncology care. Participants in the rehabilitation group experienced reduced symptom burden and functional deficits. They also showed better emotional health and social connectedness. These benefits enabled seniors to maintain independence, tolerate necessary treatments, and achieve some control over their healing journey.

Figure 1. Quality of Life Scores.

Comprehensive Geriatric Assessment: A Key to Personalised Care

Comprehensive geriatric assessment (CGA) plays a vital role in delivering patient-centred care by offering detailed insights into the medical, psychosocial, and functional capacities of older cancer patients. Through CGA, healthcare providers can tailor care plans that optimise cancer outcomes while addressing the individual health needs and goals of each patient. By evaluating factors like comorbidities, fall risk, medications, cognitive function, and nutritional status, CGA enables personalised care that enhances diagnostic accuracy, treatment tolerance, survival rates, and overall QoL for vulnerable older cancer patients.

Specialised Geriatric Cancer Rehabilitation: A Promising Approach

Geriatric-specific cancer rehabilitation interventions hold promise in addressing the complex needs of older cancer patients and improving their health outcomes. These programmes encompass a range of interventions, including physical and occupational therapy, nutritional counselling, pain management, and psychological support, aimed at enhancing patients’ physical, social, and psychological well-being. Evidence suggests that participation in multidisciplinary cancer rehabilitation programmes leads to significant improvements in physical and emotional symptoms, treatment tolerance, functional independence, and overall QoL for cancer patients across different age groups. However, persistent health system barriers limit referral and access to these programs. Addressing these barriers is crucial as cancer incidence among older adults continues to rise.

Conclusion

Geriatric-specific cancer rehabilitation offers meaningful improvements in QoL for older adults. The study highlighted the necessity for collaborative efforts between oncology and geriatrics to address the unique needs of this population. By focusing on personalised care, comprehensive assessments, and tailored rehabilitation interventions, healthcare providers can empower older cancer patients to navigate their cancer journey with resilience and improved well-being. As the population ages and cancer rates rise, it is imperative to invest in evidence-based interventions like geriatric cancer rehabilitation to ensure that older adults receive the care and support they need to enhance their QoL and overall health.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.